封面
市场调查报告书
商品编码
1948618

2026年全球辅助人工心臟市场报告

Ventricular Assist Device Global Market Report 2026

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,辅助人工心臟)的市场规模迅速扩张。预计该市场规模将从2025年的23.7亿美元成长到2026年的26.9亿美元,复合年增长率(CAGR)为13.3%。过去几年的增长归因于多种因素,例如终末期心臟衰竭患者数量的增加、供体心臟供不应求、机械循环支持技术的进步、辅助人工心臟(LVAD)疗法的临床接受度提高以及手术效果的改善。

预计未来几年,辅助人工心臟)市场规模将快速成长,到2030年将达到43.4亿美元,复合年增长率(CAGR)为12.8%。预测期内的成长要素包括:患有心臟病的老年人口不断增加、长期机械辅助装置的普及、装置耐久性技术的进步、家庭病患监测的扩展以及对先进心臟护理基础设施投资的增加。预测期内的关键趋势包括:小型化植入帮浦设计的进步、连续流装置的日益普及、远端患者监护功能的整合、生物相容性材料的更广泛应用以及终末期治疗应用的扩展。

人们对心臟衰竭治疗的认识不断提高,预计将推动辅助人工心臟)市场的扩张。心臟衰竭是指心臟功能减弱或僵硬,导致其泵血能力下降,无法有效将血液输送到全身的一种疾病。当心臟无法提供足够的血液来满足身体需求时,就会发生心臟衰竭。其主要病因包括冠状动脉疾病、心肌梗塞、高血压和心肌损伤。人们对心臟衰竭现有治疗方法的认识不断提高,正在推动辅助人工心臟作为治疗方案的普及。例如,根据英国非营利组织英国)的数据,截至2025年9月,英国心血管疾病患者人数预计将比目前水准增加约100万,到2040年将增加约200万。因此,人们对心臟衰竭治疗的认识不断提高,预计将推动对辅助人工心臟的需求。

在辅助人工心臟)市场主要企业正优先推进技术创新,包括雷射焊接技术,以实现植入式系统的微型化和轻量化,同时提升生物相容性和结构强度。采用精密雷射焊接技术,能够在不影响耐用性的前提下设计出小型轻量的泵,从而惠及更广泛的患者群体,并有助于改善长期临床疗效。例如,2024 年 3 月,中国人工心臟製造商 EVA 心臟医疗宣布推出 EVA-Pulsar,这是辅助人工心臟,采用了雷射焊接技术。这种轻量化设计能够忠实地模拟 20-30 毫米汞柱的自然脉压水平,从而支持更接近生理的心抟出量,并有助于降低与连续流装置相关的风险。 EVA-Pulsar 已获得日本监管机构的核准,目前正在美国进行临床试验。这充分展现了该装置的全球应用潜力。

目录

第一章:执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球辅助人工心臟市场:吸引力评分及分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单:主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章:全球市场趋势与策略

  • 关键科技与未来趋势
    • 生物技术、基因组学和精准医疗
    • 人工智慧(AI)和自主人工智慧
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施、互联生态系统
  • 主要趋势
    • 微型植入设计的进展
    • 连续流装置的应用日益广泛
    • 远端患者监护功能的集成
    • 改进生物相容性材料的使用
    • 扩大目的地治疗的适应症

第五章 终端用户产业市场分析

  • 医院
  • 门诊手术中心
  • 心臟病中心
  • 专科心臟诊所
  • 移植中心

第六章 市场:宏观经济情景,包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响,以及 COVID-19 疫情对市场的影响。

第七章:全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球辅助人工心臟市场:PESTEL 分析(政治、社会、技术、环境、法律因素、驱动因素和限制因素)
  • 全球辅助人工心臟市场规模、对比及成长率分析
  • 全球辅助人工心臟市场表现:规模与成长,2020-2025年
  • 全球辅助人工心臟市场预测:规模与成长,2025-2030年,2035年预测

第八章:全球市场总规模(TAM)

第九章 市场细分

  • 副产品
  • 左心室补助人工心臟(LVAD)、右心室辅助人工心臟(RVAD)、双心室辅助人工心臟(BIVAD)
  • 血液流动机制
  • 脉动流,连续流
  • 有意为之
  • 经皮辅助人工心臟,植入式辅助人工心臟
  • 透过使用
  • 移植等待期间的循环支持(BTT)、长期居家辅助人工心臟治疗、心臟功能恢復前的循环支持(BTR)以及移植登记前的循环支持(BTC)。
  • 最终用户
  • 医院、门诊手术中心、心臟科中心
  • 依类型细分:左心室补助人工心臟(LVAD)
  • 植入式左心室辅助装置,暂时性左心室辅助装置
  • 依类型细分:右心室辅助人工心臟(RVAD)
  • 植入式RVAD,临时RVAD
  • 依类型细分:双心室辅助人工心臟(BIVAD)
  • 全支撑型双腔输液港,混合型双腔输液港

第十章 区域与国别分析

  • 全球辅助人工心臟市场:依地区划分,历史资料及预测(2020-2025年、2025-2030年、2035年)
  • 全球辅助人工心臟市场:依国家划分,实际值及预测值,2020-2025 年、2025-2030 年预测值、2035 年预测值

第十一章 亚太市场

第十二章:中国市场

第十三章:印度市场

第十四章:日本市场

第十五章:澳洲市场

第十六章:印尼市场

第十七章:韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章:德国市场

第23章:法国市场

第24章:义大利市场

第25章:西班牙市场

第26章:东欧市场

第27章:俄罗斯市场

第28章 北美市场

第29章:美国市场

第三十章:加拿大市场

第31章:南美市场

第32章:巴西市场

第33章 中东市场

第34章:非洲市场

第三十五章 市场监理与投资环境

第36章:竞争格局与公司概况

  • 辅助人工心臟市场:竞争格局及市场占有率(2024年)
  • 辅助人工心臟市场:公司估价矩阵
  • 辅助人工心臟市场:公司概况
    • Abiomed
    • Abbott Laboratories
    • Medtronic
    • LivaNova PLC
    • Terumo Corporation

第37章 其他大型企业和创新企业

  • Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC, Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., CorWave SA, CH Biomedical(USA)Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International

第38章:全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章:高潜力市场国家、细分市场与策略

  • 2030年辅助人工心臟市场:提供新机会的国家
  • 2030年辅助人工心臟市场:充满新机会的细分市场
  • 2030年辅助人工心臟市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第41章附录

简介目录
Product Code: ME4MVADS01_G26Q1

A ventricular assist device (VAD) is an implantable mechanical circulatory device used to treat heart failure by aiding blood circulation throughout the body, supporting vital organ function. The US FDA has approved a diverse range of VADs, offering long-term or permanent assistance for patients with end-stage heart failure.

The primary types of VADs include left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BIVADs). LVADs, battery-operated mechanical pumps, help propel blood from the left ventricle to vital organs. They vary in design as transcutaneous or implantable devices and operate with different flow mechanisms such as pulsatile flow and continuous flow. These devices are used for various purposes including bridge-to-transplant (BTT) therapy, destination therapy, bridge-to-recovery (BTR) therapy, and bridge-to-candidacy (BTC) therapy. End-users of VADs include hospitals, ambulatory surgical centers, and cardiology centers.

Tariffs are impacting the ventricular assist device market by increasing costs of imported medical-grade metals, precision motors, sensors, electronic control units, and sterilized components used in implantable circulatory systems. North America and Europe are most affected due to reliance on specialized cross-border medical device supply chains, while Asia-Pacific faces cost pressure in advanced device manufacturing. These tariffs are raising production costs and contributing to higher device pricing for hospitals. However, they are also encouraging localized manufacturing, regional supplier development, and greater investment in domestic medical device production capabilities.

The ventricular assist device market research report is one of a series of new reports from The Business Research Company that provides ventricular assist device market statistics, including ventricular assist device industry global market size, regional shares, competitors with a ventricular assist device market share, detailed ventricular assist device market segments, market trends and opportunities, and any further data you may need to thrive in the ventricular assist device industry. This ventricular assist device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ventricular assist device market size has grown rapidly in recent years. It will grow from $2.37 billion in 2025 to $2.69 billion in 2026 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to increasing prevalence of end-stage heart failure, limited availability of donor hearts, advancements in mechanical circulatory support technologies, rising clinical acceptance of LVAD therapy, improved surgical outcomes.

The ventricular assist device market size is expected to see rapid growth in the next few years. It will grow to $4.34 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to increasing aging population with cardiac disorders, rising adoption of long-term mechanical support, technological advancements in device durability, expansion of home-based patient monitoring, growing investments in advanced cardiac care infrastructure. Major trends in the forecast period include advancements in miniaturized implantable pump designs, growing adoption of continuous-flow devices, integration of remote patient monitoring capabilities, improved biocompatible materials usage, expansion of destination therapy applications.

Growing awareness of heart failure treatment is anticipated to support the expansion of the ventricular assist device market. Heart failure is a condition in which the heart becomes weakened or stiff, reducing its ability to pump blood efficiently throughout the body. It occurs when the heart cannot supply sufficient blood to meet the body's needs, with common causes including coronary artery disease, heart attacks, hypertension, and damage to the heart muscle. Increased awareness of available treatment options for heart failure is encouraging broader adoption of ventricular assist devices as a therapeutic solution. For instance, in September 2025, according to the British Heart Foundation, a United Kingdom-based nonprofit organization, the number of people living with cardiovascular disease in the United Kingdom could increase by approximately 1 million by 2030 and by around 2 million by 2040 compared with current levels. As a result, rising awareness of heart failure treatment is expected to drive demand for ventricular assist devices.

Leading companies operating in the ventricular assist device market are prioritizing technological innovations, including laser-welding techniques, to reduce the size and weight of implantable systems while improving biocompatibility and structural strength. The use of precision laser welding enables manufacturers to design smaller and lighter pumps without sacrificing durability, making these devices suitable for a broader patient population and supporting improved long-term clinical outcomes. For example, in March 2024, Evaheart Medical, a China-based artificial heart company, introduced its EVA-Pulsar ventricular assist device, which weighs just 262 grams due to the use of laser-welding technology. The lightweight design closely replicates natural pulse pressure levels of 20-30 millimeters of mercury and supports more physiological cardiac output, helping to reduce risks associated with continuous-flow devices. The EVA-Pulsar has received regulatory approval in Japan, and clinical trials are ongoing in the United States, highlighting its global potential.

In October 2024, Johnson & Johnson, a United States-based healthcare company, completed the acquisition of V Wave Ltd. for an undisclosed consideration. Through this transaction, Johnson & Johnson seeks to strengthen its cardiovascular portfolio by incorporating V Wave's minimally invasive Ventura Interatrial Shunt, which is designed to reduce elevated left atrial pressure in patients with heart failure with reduced ejection fraction. V Wave Ltd. is an Israel-based medical device company specializing in the development of implantable solutions for heart failure through structural interventional cardiology.

Major companies operating in the ventricular assist device market are Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC, Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

North America was the largest region in the ventricular assist device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ventricular assist device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The ventricular assist device market consists of sales of pulsatile and nonpulsatile LVADs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ventricular Assist Device Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses ventricular assist device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ventricular assist device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ventricular assist device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Left Ventricular Assist Devices (LVADs); Right Ventricular Assist Devices (RVADs); Biventricular Assist Devices (BIVADs)
  • 2) By Flow Mechanism: Pulsatile Flow; Continuous Flow
  • 3) By Design: Transcutaneous Ventricular Assist Devices; Implantable Ventricular Assist Devices
  • 4) By Application: Bridge-To-Transplant (BTT) Therapy; Destination Therapy; Bridge-To-Recovery (BTR) Therapy; Bridge-To-Candidacy (BTC) Therapy
  • 5) By End Users: Hospital; Ambulatory Surgical Centres; Cardiology Centres
  • Subsegments:
  • 1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs; Temporary LVADs
  • 2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs; Temporary RVADs
  • 3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs; Hybrid BIVADs
  • Companies Mentioned: Abiomed; Abbott Laboratories; Medtronic; LivaNova PLC; Terumo Corporation; Berlin Heart GmbH; Cirtec; Jarvik Heart Inc.; SynCardia Systems LLC; Calon Cardio-Technology Ltd; Huadong Medicine Co. Ltd; Shenzhen Hexin Zondan Medical Equipment Co. Ltd; Sun Medical Technology Research Corp.; CorWave SA; CH Biomedical (USA) Inc; Evaheart Inc; BiVACOR Inc; ReliantHeart Inc; Cardiac Assist Inc; Heart Ware International; Braile Biomedica Ltd
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Ventricular Assist Device Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Ventricular Assist Device Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Ventricular Assist Device Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Ventricular Assist Device Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Advancements In Miniaturized Implantable Pump Designs
    • 4.2.2 Growing Adoption Of Continuous-Flow Devices
    • 4.2.3 Integration Of Remote Patient Monitoring Capabilities
    • 4.2.4 Improved Biocompatible Materials Usage
    • 4.2.5 Expansion Of Destination Therapy Applications

5. Ventricular Assist Device Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centres
  • 5.3 Cardiology Centres
  • 5.4 Specialty Heart Clinics
  • 5.5 Transplant Centres

6. Ventricular Assist Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Ventricular Assist Device Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Ventricular Assist Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Ventricular Assist Device Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Ventricular Assist Device Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Ventricular Assist Device Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Ventricular Assist Device Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Ventricular Assist Device Market Segmentation

  • 9.1. Global Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs)
  • 9.2. Global Ventricular Assist Device Market, Segmentation By Flow Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pulsatile Flow, Continuous Flow
  • 9.3. Global Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices
  • 9.4. Global Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy
  • 9.5. Global Ventricular Assist Device Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital, Ambulatory Surgical Centres, Cardiology Centres
  • 9.6. Global Ventricular Assist Device Market, Sub-Segmentation Of Left Ventricular Assist Devices (LVADs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Implantable LVADs, Temporary LVADs
  • 9.7. Global Ventricular Assist Device Market, Sub-Segmentation Of Right Ventricular Assist Devices (RVADs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Implantable RVADs, Temporary RVADs
  • 9.8. Global Ventricular Assist Device Market, Sub-Segmentation Of Biventricular Assist Devices (BIVADs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Full Support BIVADs, Hybrid BIVADs

10. Ventricular Assist Device Market Regional And Country Analysis

  • 10.1. Global Ventricular Assist Device Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Ventricular Assist Device Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Ventricular Assist Device Market

  • 11.1. Asia-Pacific Ventricular Assist Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Ventricular Assist Device Market

  • 12.1. China Ventricular Assist Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Ventricular Assist Device Market

  • 13.1. India Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Ventricular Assist Device Market

  • 14.1. Japan Ventricular Assist Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Ventricular Assist Device Market

  • 15.1. Australia Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Ventricular Assist Device Market

  • 16.1. Indonesia Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Ventricular Assist Device Market

  • 17.1. South Korea Ventricular Assist Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Ventricular Assist Device Market

  • 18.1. Taiwan Ventricular Assist Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Ventricular Assist Device Market

  • 19.1. South East Asia Ventricular Assist Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Ventricular Assist Device Market

  • 20.1. Western Europe Ventricular Assist Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Ventricular Assist Device Market

  • 21.1. UK Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Ventricular Assist Device Market

  • 22.1. Germany Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Ventricular Assist Device Market

  • 23.1. France Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Ventricular Assist Device Market

  • 24.1. Italy Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Ventricular Assist Device Market

  • 25.1. Spain Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Ventricular Assist Device Market

  • 26.1. Eastern Europe Ventricular Assist Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Ventricular Assist Device Market

  • 27.1. Russia Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Ventricular Assist Device Market

  • 28.1. North America Ventricular Assist Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Ventricular Assist Device Market

  • 29.1. USA Ventricular Assist Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Ventricular Assist Device Market

  • 30.1. Canada Ventricular Assist Device Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Ventricular Assist Device Market

  • 31.1. South America Ventricular Assist Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Ventricular Assist Device Market

  • 32.1. Brazil Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Ventricular Assist Device Market

  • 33.1. Middle East Ventricular Assist Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Ventricular Assist Device Market

  • 34.1. Africa Ventricular Assist Device Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Ventricular Assist Device Market, Segmentation By Product, Segmentation By Flow Mechanism, Segmentation By Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Ventricular Assist Device Market Regulatory and Investment Landscape

36. Ventricular Assist Device Market Competitive Landscape And Company Profiles

  • 36.1. Ventricular Assist Device Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Ventricular Assist Device Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Ventricular Assist Device Market Company Profiles
    • 36.3.1. Abiomed Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Medtronic Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Ventricular Assist Device Market Other Major And Innovative Companies

  • Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC, Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International

38. Global Ventricular Assist Device Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Ventricular Assist Device Market

40. Ventricular Assist Device Market High Potential Countries, Segments and Strategies

  • 40.1 Ventricular Assist Device Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Ventricular Assist Device Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Ventricular Assist Device Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer